Identification of key genes in benign prostatic hyperplasia using bioinformatics analysis
Identification of key genes in benign prostatic hyperplasia using bioinformatics analysis
复制标题
利用生物信息学分析鉴定良性前列腺增生的关键基因
DOI:
10.1007/s00345-021-03625-5
复制
发表时间:
2021-02-09
影响因子:
3.4
通讯作者:
Ping, Hao
中科院分区:
文献类型:
--
作者:
Xiang, Peng;Liu, Dan;Ping, Hao
PurposeThis study aimed to identify differentially expressed genes (DEGs) and pathways in benign prostatic hyperplasia (BPH) by comprehensive bioinformatics analysis.MethodsData of the gene expression microarray (GSE6099) were downloaded from GEO database. DEGs were obtained by GEO2R. Functional and enrichment analyses of selected genes were performed using DAVID database. Protein–protein interaction network was constructed through STRING. Anterior gradient 2 (ARG2) and lumican (LUM) staining in paraffin-embedded specimens from BPH and normal prostate (NP) were detected by immunohistochemistry (IHC). Differences between groups were analyzed by the Student’sttest.ResultsA total of 24 epithelial DEGs and 39 stromal DEGs were determined. The GO analysis results showed that epithelial DEGs between BPH and NP were enriched in biological processes of glucose metabolic process, glucose homeostasis and negative regulation of Rho protein signal transduction. For DEGs in stroma, enriched biological processes included response to ischemia, antigen processing and presentation, cartilage development, T cell costimulation and energy reserve metabolic process. ARG2, as one of the epithelial DEGs, was mainly located in epithelial cells of prostate. In addition, LUM is primarily expressed in the stroma. We further confirmed that compared with NP, the BPH have the lower ARG2 protein level (p= 0.029) and higher LUM protein level (p= 0.003) using IHC.ConclusionsOur study indicated that there are possible differentially expressed genes in epithelial and stromal cells, such as ARG2 and LUM, which may provide a novel insight for the pathogenesis of BPH.